• FirefoxInstall the new Firefox »
  •  Dow Up 1.56% Nasdaq Up 0.98%

    ImmunoGen, Inc. (IMGN)

    -NasdaqGS
    8.53 Up 0.28(3.42%) 12:38PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:8.25
    Open:8.31
    Bid:8.50 x 600
    Ask:8.52 x 6400
    1y Target Est:7.69
    Beta:1.27
    Next Earnings Date:24-Apr-15IMGN Earnings announcement
    Day's Range:8.20 - 8.73
    52wk Range:5.34 - 15.59
    Volume:910,861
    Avg Vol (3m):1,604,310
    Market Cap:734.70M
    P/E (ttm):N/A
    EPS (ttm):-0.85
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IMGN

    Comparison

    Symbol% ChgMkt Cap
    IMGNUp 3.42%734.70M
    PFEUp 1.30%214.38B
    RHHBYUp 0.03%N/A
    SGENUp 0.03%4.50B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):9.58
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-15) :-0.65
    Quarterly EPS Est (Mar-15) :-0.25
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. It develops its products using its antibody-drug conjugates technology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback